Canvas examples
Download as PPTX, PDF95 likes112,356 views
The document describes a business model canvas for a company targeting recombinant hemagglutinin (HA) for pandemic and seasonal influenza. Key elements include relying on gene synthesis companies, CMOs for manufacturing, and pursuing regulatory approval, speed, cost-effectiveness, and scalability. Distribution would be through government agencies and pharmaceutical companies. Revenue streams include capital investments, manufacturing contracts, and licensing royalties. The goal is to secure long-term contracts with government agencies and vaccine manufacturers in both the US and abroad.
Canvas examples
- 1. The Business Model Canvas Target Product – Recombinant hemagglutinin (HA) for pandemic and seasonal influenza Tobacco Suppliers R&D Speed Long-Term U.S. Government Gene Synthesis Manufacturing Cost-Effectiveness Contracts with - CDC Companies Regulatory Approval Robustness Government and - HHS BARDA CMOs Licensing Scalability Vaccine - DOD DARPA - Purification Marketing Safety Manufacturers Foreign Governments - Fill & Finish Ease of Customization NGOs - Packaging U.S. Supply Vaccine Manufacturers - QA/QC -Established and CROs Emerging Biotech - Clinical Trials FDA IP – Patents, Trade Secret Manufacturing Facility Distribution through Government and Pharma Companies Capital Investments Contract Manufacturing Manufacturing Costs Fully Integrated Manufacturing (Sales) Licensing Costs Licensing (Royalties) Marketing
- 2. The Business Model Canvas Target Product – glucocerebrosidase Conferences Tobacco Suppliers R&D Speed Long-Term U.S. Government Gene Synthesis Manufacturing Cost-Effectiveness Contracts with - CDC Companies Regulatory Approval Robustness Government and - HHS BARDA CMOs Licensing Scalability Vaccine - DOD DARPA - Purification Marketing Safety Manufacturers Foreign Governments - Fill & Finish Ease of Customization Pharma NGOs - Packaging U.S. Supply Wholesalers Vaccine Manufacturers - QA/QC Improved Product Pharma Companies CROs Quality - Established and - Clinical Trials Emerging Biotech FDA IP – Patents, Trade Secret Manufacturing Facility Distribution through Government and Pharma Companies Capital Investments Contract Manufacturing Manufacturing Costs Fully Integrated Manufacturing (Sales) Licensing Costs Licensing for Specific Targetsor Specific Marketing Worldwide Regions (Royalties)
- 4. The Business Model Canvas: ver 0.0 Privacy Creating Increased educational advocacy Privacy- awareness privacy groups trust concerned customers Building trust who use LBS LBS App Providers Technology Own website Bundling with LBS apps Developing App revenue (direct or shared) costs Marketing costs
- 5. The Business Model Canvas: ver 0.1 Privacy Creating Increased educational advocacy awareness Privacy- privacy groups trust concerned customers Building trust LBS App No loss of who use LBS Providers service quality Smart phone users uneasy about privacy Technology Own website Bundling with LBS apps Developing App revenue (direct or shared) costs Marketing Subscription costs